Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $168M | $225M | $336M | $341M | $280M | $312M | $321M | $252M | $279M | $295M |
| Revenue growth | — | 34.1% | 49.0% | 1.3% | -17.7% | 11.3% | 2.8% | -21.5% | 10.8% | 5.9% |
| Gross profit | $97.3M | $121M | $179M | $172M | $138M | $176M | $154M | $127M | $155M | $154M |
| Gross margin | 57.9% | 53.8% | 53.1% | 50.5% | 49.3% | 56.6% | 47.9% | 50.4% | 55.5% | 52.2% |
| Operating income | $22.9M | $27.6M | $37.9M | $19.8M | -$12.0M | $9.24M | -$85.2M | -$109M | -$42.5M | -$30.2M |
| Operating margin | 13.6% | 12.2% | 11.3% | 5.8% | -4.3% | 3.0% | -26.6% | -43.5% | -15.3% | -10.2% |
| Net income | $20.5M | $21.0M | $51.8M | $20.9M | -$5.83M | -$6.33M | -$83.8M | -$102M | -$35.9M | -$22.7M |
| Net margin | 12.2% | 9.3% | 15.4% | 6.2% | -2.1% | -2.0% | -26.1% | -40.7% | -12.9% | -7.7% |
| EPS (diluted) | $0.97 | $0.96 | $2.30 | $0.94 | -$0.27 | -$0.28 | -$3.67 | -$4.42 | -$1.52 | -$0.86 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $31.0M | $60.5M | $60.0M | $40.6M | $37.0M | $23.6M | -$37.5M | -$3.23M | $5.91M | -$11.2M |
| Capital expenditures | $1.72M | $2.91M | $8.04M | $3.14M | $4.38M | $5.48M | $3.34M | $5.22M | $3.36M | $2.52M |
| Free cash flow | $29.3M | $57.6M | $51.9M | $37.5M | $32.6M | $18.2M | -$40.9M | -$8.45M | $2.55M | -$13.7M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $92.9M | $143M | $197M | $198M | $212M | $236M | $187M | $125M | $114M | $104M |
| Total assets | $214M | $275M | $376M | $447M | $462M | $490M | $405M | $326M | $296M | $299M |
| Total liabilities | $32.0M | $48.0M | $65.5M | $103M | $112M | $119M | $108M | $121M | $122M | $106M |
| Shareholders' equity | $182M | $227M | $310M | $345M | $350M | $370M | $297M | $205M | $174M | $192M |
| Retained earnings | -$12.4M | $8.64M | $60.5M | $81.4M | $75.6M | $69.3M | -$14.5M | -$117M | -$153M | -$176M |
| Shares (wtd avg diluted) | 21.1M | 21.9M | 22.5M | 22.2M | 22.0M | 22.5M | 22.9M | 23.2M | 23.7M | 26.6M |
Every figure is extracted from Inogen Inc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.